PR87511

NOTTINGHAM, England, Jan. 11, 2021 /PRNewswire=KYODO JBN/ --

-- Formerly Parexel Informatics, Calyx is a market-leading Medical Imaging,

eClinical, and Regulatory solutions provider

Calyx (https://www.calyx.ai/?utm_campaign=discover&utm_source=newswire&utm_medium=referral&utm_content=0111-pr),

a leading provider of Medical Imaging, eClinical, and Regulatory solutions

and services to solve complex challenges in clinical research, today launched

as an independent company following the strategic separation of the Parexel

Informatics business from Parexel International.

Video - https://mma.prnewswire.com/media/1396346/Calyx_Brand_Video.mp4

Logo - https://mma.prnewswire.com/media/1396338/Calyx_Logo.jpg

With 250 new drug approvals in its history, Calyx has supported over 25,000

trials involving more than fourteen million patients. The company will continue

its focus on providing innovative technology solutions and services to speed

the discovery of new treatments.

"Today our industry needs to move at a 21st century pace and Calyx, as an

independent company, is focused on enabling global biopharmaceutical customers

and clinical research organizations (CROs) to leverage innovative technology

solutions and services in the pursuit of cures," said Gavin Nichols, Chief

Executive Officer at Calyx. "While the name is new, Calyx has a long history of

solving complex problems to accelerate new product development – from selecting

the right biomarker in early stage imaging to the electronic management of entire

global development programs. We're excited about this next stage of our journey."

Calyx will remain privately held by the same ownership group that has owned and

invested in Parexel since 2017.

Learn more at calyx.ai

(https://www.calyx.ai/?utm_campaign=discover&utm_source=newswire&utm_medium=referral&utm_content=0111-pr )

About Calyx

Through innovative eClinical solutions and services, Calyx turns the uncertain

into the reliable, helping bring new medical treatments to market faster. With

deep expertise in clinical development and more than 25 years of supporting

trial sponsors and clinical research organizations (CROs), Calyx harnesses that

intelligence and activates its potential to solve complex problems, deliver

fast insights, and get new drugs to market every day.

Medical Imaging | IRT | CTMS | EDC | RIM

Take your trials further, faster at calyx.ai (https://www.calyx.ai/?utm_campaign=discover&utm_source=newswire&utm_medium=referral&utm_content=0111-pr ),

LinkedIn ( https://www.linkedin.com/company/71076865 ), Twitter (https://twitter.com/calyxai ),

or Facebook ( https://www.facebook.com/calyxai ).

SOURCE: Calyx

CONTACT: Christine Tobin | +412-628-8598 | christine.tobin@calyx.ai